American Heart Association Scientific Sessions 2020
Blacks, Hispanics Had Higher Rates of Hospitalization, Mortality from COVID-19
According to new data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, Black and Hispanic patients accounted for more than half of hospitalizations...
High-Dose Influenza Vaccine Similar to Standard-Dose for All-Cause Death, Cardiopulmonary Events
High-dose inactivated influenza vaccine did not reduce all-cause death or hospitalization for cardiopulmonary causes compared with a standard-dose vaccine in patients with high-risk cardiovascular...
Rivaroxaban Plus Aspirin Reduced Cardiac, Limb Events in PAD After LER
Rivaroxaban plus aspirin reduced ischemic risk of the limb, brain, and heart in peripheral artery disease (PAD) after lower extremity revascularization (LER), according to...
Rivaroxaban Monotherapy Safe for AF After Coronary Stenting
The benefit of rivaroxaban monotherapy for patients with atrial fibrillation (AF) after coronary stenting was dependent on the duration of time from stenting, according...
40% of Middle-Aged Swedes Had Silent CAD
Four out of 10 people in a middle-age population in Sweden had coronary artery disease (CAD), with one in 20 having severe CAD, according...
Rates of Thromboembolic Complications High in COVID-19+ ICU Patients
Patients in the intensive care unit (ICU) for COVID-19 had high rates of major arterial or venous thromboembolism (VTE), major adverse cardiovascular events, and...
Rivaroxaban Plus Aspirin Protects Against Venous, Arterial Thrombotic Events After LER
Peripheral artery disease (PAD) was associated with continuous and linearly increasing risk for venous thromboembolism (VTE) after lower extremity revascularization (LER). Low-dose rivaroxaban plus...
Recent Cardiology Headlines
Cardio Round-Up: Heart Transplants from Past Drug Users Safe; The ABC’s of CVD Prevention;...
Patients Who Receive Heart Transplants from Donors Who Use Illicit Drugs Have Unaffected Survival Rates
Heart transplant recipients have unaffected survival rates if they receive...
Patients Who Receive Heart Transplants from Donors Who Use Illicit Drugs Have Unaffected Survival...
Heart transplant recipients have unaffected survival rates if they receive a transplant from an organ donor who used illicit drugs or died due to...
AFib in Hospitalized COVID-19 Patients Associated with a Two-Fold Risk of Dying
A study shows that about one in ten hospitalized patients with SARS-CoV-2 (COVID-19) have atrial fibrillation (AFib), and these patients suffer more comorbidities and...
Risk Factors ID’d for VTE, ASCVD in Rheumatoid Arthritis Patients
For patients with rheumatoid arthritis, there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD...